(Q35001306)

5 August 2017

1 reference

title

Context in the clinic: how well do cognitive-behavioral therapies and medications work in combination? (English)

1 reference

5 August 2017

1

Edna B Foa

1 reference

5 August 2017

Martin E Franklin

2

1 reference

5 August 2017

Jason Moser

series ordinal

3

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

5 August 2017

published in

Biological Psychiatry

1 reference

5 August 2017

volume

52

1 reference

5 August 2017

issue

10

1 reference

5 August 2017

page(s)

987-997

1 reference

Variants of exposure and response prevention in the treatment of obsessive-compulsive disorder: A meta-analysis

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative review

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

Alprazolam and exposure for panic disorder with agoraphobia. Attribution of improvement to medication predicts subsequent relapse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

Randomised controlled general practice trial of sertraline, exposure therapy and combined treatment in generalised social phobia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

A learning theory perspective on lapse, relapse, and the maintenance of behavior change

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

The assessment and treatment of performance anxiety in musicians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

A cognitive approach to panic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

A controlled study of cognitive behaviour therapy with buspirone or placebo in panic disorder with agoraphobia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

Treatment of panic disorder with agoraphobia: comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

The treatment of social phobia. Real-life rehearsal with nonprofessional therapists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

Treatment of depressive and obsessive-compulsive symptoms in OCD by imipramine and behaviour therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

Severe agoraphobia: a controlled prospective trial of behaviour therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

The Yale-Brown Obsessive Compulsive Scale. II. Validity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

Cognitive-Behavioral and Pharmacological Treatment for Social Phobia: A Meta-Analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

The assessment of anxiety states by rating

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

Desensitization and Flooding (Implosion) in Treatment of Phobias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

Imipramine and Brief Therapist-Aided Exposure in Agoraphobics Having Self-exposure Homework

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

Clomipramine, self-exposure and therapist-aided exposure for obsessive-compulsive rituals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

Clomipramine and exposure for obsessive-compulsive rituals: i

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

Enhanced Relief of Phobias by Flooding During Waning Diazepam Effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

Pharmacological treatment of agoraphobia: imipramine versus imipramine with programmed practice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

Discontinuation of benzodiazepine treatment: efficacy of cognitive- behavioral therapy for patients with panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

Duration of flooding sessions in the treatment of obsessive-compulsive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

A cognitive-behavioral model of anxiety in social phobia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

Pavlovian conditioning: It's not what you think it is

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

Obsessional-compulsive problems: a cognitive-behavioural analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

Multicenter collaborative panic disorder severity scale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

Brief and prolonged flooding. A comparison in agoraphobic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

Combined pharmacological and behavioral treatment for agoraphobia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

Comparative efficacy of treatments for post-traumatic stress disorder: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

Treatment of Agoraphobia With Group Exposure In Vivo and Imipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

Treatment choice for PTSD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901552-4

10.1016/S0006-3223(02)01552-4

7 January 2021

Identifiers

DOI

1 reference

5 August 2017

1 reference